{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:26:46Z","timestamp":1790872006165,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.jneuroim.2009.03.006","type":"journal-article","created":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T04:53:02Z","timestamp":1238561582000},"page":"87-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome"],"prefix":"10.1016","volume":"210","author":[{"given":"V.","family":"F\u00fchlhuber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kirsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gerriets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tschernatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.T.","family":"Preissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Altenk\u00e4mper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2009.03.006_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00005792-198803000-00003","article-title":"Opsoclonus, myoclonus, ataxia, and encephalopathy in adults with cancer: a distinct paraneoplastic syndrome","volume":"67","author":"Anderson","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2009.03.006_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00043426-200007000-00007","article-title":"Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus","volume":"22","author":"Antunes","year":"2000","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.10462","article-title":"Autoantigen diversity in the opsoclonus-myoclonus syndrome","volume":"53","author":"Bataller","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/1531-8249(200004)47:4<504::AID-ANA14>3.0.CO;2-Q","article-title":"IgG from \u201cseronegative\u201d myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor","volume":"47","author":"Blaes","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.20539","article-title":"Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome","volume":"58","author":"Blaes","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20032000","article-title":"TACI and BAFF-R mediate isotype switching in B cells","volume":"201","author":"Castigli","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib8","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S","article-title":"Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases","volume":"44","author":"Cheema","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib9","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0022-3476(97)70272-5","article-title":"Serum autoantibodies in childhood opsoclonus-myoclonus syndrome: an analysis of antigenic targets in neural tissues","volume":"130","author":"Connolly","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(03)00374-0","article-title":"Childhood opsoclonus myoclonus","volume":"2","author":"Dale","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib11","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1002\/eji.200636270","article-title":"Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells","volume":"36","author":"Fletcher","year":"2006","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s10875-005-4091-5","article-title":"Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome","volume":"25","author":"Jonsson","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.0105-2896.2005.00219.x","article-title":"The role of BAFF in immune function and implications for autoimmunity","volume":"204","author":"Kalled","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib14","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1159\/000082105","article-title":"The biochemistry and biology of BAFF, APRIL and their receptors","volume":"8","author":"Kalled","year":"2005","journal-title":"Curr. Dir. Autoimmun."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jneuroim.2005.08.018","article-title":"Functional characterisation of autoantibodies from patients with pediatric opsoclonus-myoclonus-syndrome","volume":"170","author":"Korfei","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20041674","article-title":"BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma","volume":"201","author":"Krumbholz","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib17","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1568-9972(02)00146-5","article-title":"Autoantibodies to ion channels at the neuromuscular junction","volume":"2","author":"Lang","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ana.410290303","article-title":"Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer","volume":"29","author":"Luque","year":"1991","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib19","first-page":"157","article-title":"[Pathophysiology of Sjogren's syndrome]","volume":"154","author":"Mariette","year":"2003","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.jneuroim.2009.03.006_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0625.2006.00485.x","article-title":"Elevated serum BAFF levels in patients with localized scleroderma in contrast to other organ-specific autoimmune diseases","volume":"16","author":"Matsushita","year":"2007","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-5728(87)90088-9","article-title":"Anti-neurofilament protein antibodies in opsoclonus-myoclonus","volume":"15","author":"Noetzel","year":"1987","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199619010-00001","article-title":"The immunopharmacology of the opsoclonus-myoclonus syndrome","volume":"19","author":"Pranzatelli","year":"1996","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib23","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0887-8994(02)00457-5","article-title":"Screening for autoantibodies in children with opsoclonus-myoclonus-ataxia","volume":"27","author":"Pranzatelli","year":"2002","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/mds.20125","article-title":"CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity","volume":"19","author":"Pranzatelli","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.jneuroim.2009.03.006_bib26","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1002\/art.11354","article-title":"B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations","volume":"48","author":"Stohl","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2009.03.006_bib27","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1002\/art.21138","article-title":"BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus","volume":"52","author":"Stohl","year":"2005","journal-title":"Arthritis Rheum."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572809000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:11:40Z","timestamp":1759047100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572809000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":27,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["S0165572809000964"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.03.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2009.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}